dc.contributor.author | Gasparyan, A. Y. | |
dc.contributor.author | Manna, R. | |
dc.contributor.author | Ben-Chetrit, E. | |
dc.contributor.author | Livneh, A. | |
dc.contributor.author | Ozdogan, H. | |
dc.contributor.author | La Regina, M. | |
dc.date.accessioned | 2021-03-04T14:10:09Z | |
dc.date.available | 2021-03-04T14:10:09Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | La Regina M., Ben-Chetrit E., Gasparyan A. Y. , Livneh A., Ozdogan H., Manna R., "Current trends in colchicine treatment in familial Mediterranean fever", CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.31, sa.3, 2013 | |
dc.identifier.issn | 0392-856X | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_801cf3c6-daf9-4fa6-96ec-e066d8759361 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/87408 | |
dc.description.abstract | Objectives. Since the publication of the first reports on the efficiency of colchicine in familial Mediterranean fever (FMF), very few randomised studies have investigated issues related to its long-term use. Thus, different approaches taken by physicians involved in FMF care, are exclusively empiric, emulative, and based on case-reports or case-series. Problems such as colchicine intolerance and colchicine resistance have not been solved yet. This paper aims to evaluate trends in colchicine therapy among physicians taking care of FMF patients around the world. | |
dc.language.iso | eng | |
dc.subject | İmmünoloji ve Romatoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ROMATOLOJİ | |
dc.title | Current trends in colchicine treatment in familial Mediterranean fever | |
dc.type | Makale | |
dc.relation.journal | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | |
dc.contributor.department | Catholic University of the Sacred Heart , , | |
dc.identifier.volume | 31 | |
dc.identifier.issue | 3 | |
dc.contributor.firstauthorID | 209036 | |